Effect of P. gingivalis on osimertinib resistance in EGFR-mutant lung cancer

被引：0
|
作者：
Li, Wendong
Rotter-Maskowitz, Aviva
Zhang, Keqiang
Massarelli, Erminia
Potempa, Jan
Straussman, Ravid
Raz, Dan
机构：
[1] City Hope Natl Med Ctr, Duarte, CA USA
[2] Weizmann Inst Sci, Rehovot, Israel
[3] City Hope Natl Med Ctr, Duarte, CA USA
[4] City Hope Natl Med Ctr, Ctr Comprehens Canc, Dept Med Oncol & Therapeut Res, Duarte, CA USA
[5] Univ Louisville, Louisville, KY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20511
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Combatting acquired resistance to osimertinib in EGFR-mutant lung cancer
    Lee, Jiyun
    Piotrowska, Zofia
    Soo, Ross
    Cho, Byoung Chul
    Lim, Sun Min
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [2] Tackling Osimertinib Resistance in EGFR-Mutant Non-Small Cell Lung Cancer
    Blaquier, Juan Bautista
    Ortiz-Cuaran, Sandra
    Ricciuti, Biagio
    Mezquita, Laura
    Cardona, Andres Felipe
    Recondo, Gonzalo
    [J]. CLINICAL CANCER RESEARCH, 2023, 29 (18) : 3579 - 3591
  • [3] Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancer
    Adua, Sally J.
    Arnal-Estape, Anna
    Zhao, Minghui
    Qi, Bowen
    Liu, Zongzhi Z.
    Kravitz, Carolyn
    Hulme, Heather
    Strittmatter, Nicole
    Lopez-Giraldez, Francesc
    Chande, Sampada
    Albert, Alexandra E.
    Melnick, Mary-Ann
    Hu, Bomiao
    Politi, Katerina
    Chiang, Veronica
    Colclough, Nicola
    Goodwin, Richard J. A.
    Cross, Darren
    Smith, Paul
    Nguyen, Don X.
    [J]. NATURE COMMUNICATIONS, 2022, 13 (01)
  • [4] Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancer
    Sally J. Adua
    Anna Arnal-Estapé
    Minghui Zhao
    Bowen Qi
    Zongzhi Z. Liu
    Carolyn Kravitz
    Heather Hulme
    Nicole Strittmatter
    Francesc López-Giráldez
    Sampada Chande
    Alexandra E. Albert
    Mary-Ann Melnick
    Bomiao Hu
    Katerina Politi
    Veronica Chiang
    Nicola Colclough
    Richard J. A. Goodwin
    Darren Cross
    Paul Smith
    Don X. Nguyen
    [J]. Nature Communications, 13
  • [5] Mechanisms of resistance for osimertinib for patients with EGFR-mutant lung cancer: MD Anderson Cancer Center single institution experience with osimertinib resistance
    Le, Xiuning
    Negrao, Marcelo Vailati
    Nilsson, Monique
    Robichaux, Jacqulyne
    Roarty, Emily
    Rinsurongkawong, Waree
    Glisson, Bonnie
    Zhang, Jianjun
    Heymach, John V.
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [6] MERTK activation drives osimertinib resistance in EGFR-mutant non small cell lung cancer
    Yan, Dan
    Huelse, Justus M.
    Kireev, Dmitri
    Tan, Zikang
    Chen, Luxiao
    Goyal, Subir
    Wang, Xiaodong
    Frye, Stephen, V
    Behera, Madhusmita
    Schneider, Frank
    Ramalingam, Suresh S.
    Owonikoko, Taofeek
    Earp, H. Shelton
    DeRyckere, Deborah
    Graham, Douglas K.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (15):
  • [7] Dihydroartemisinin overcomes the resistance to osimertinib in EGFR-mutant non-small-cell lung cancer
    Cai, Xueting
    Miao, Jing
    Sun, Rongwei
    Wang, Sainan
    Molina-Vila, Miguel Angel
    Chaib, Imane
    Rosell, Rafael
    Cao, Peng
    [J]. PHARMACOLOGICAL RESEARCH, 2021, 170
  • [8] Mechanisms of Osimertinib Resistance in EGFR Mutant Lung Cancer
    Westover, D.
    Qiao, H.
    Ichihara, E.
    Meador, C. B.
    Lovly, C. M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (08) : S1546 - S1546
  • [9] Overcoming acquired resistance following osimertinib administration in EGFR-mutant lung adenocarcinoma
    Kaira, Kyoichi
    Imai, Hisao
    Kagamu, Hiroshi
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (05) : 1177 - 1182
  • [10] Overcoming therapy resistance in EGFR-mutant lung cancer
    Antonio Passaro
    Pasi A. Jänne
    Tony Mok
    Solange Peters
    [J]. Nature Cancer, 2021, 2 : 377 - 391
12345